Brief: Marker Therapeutics Awarded $9.5 Mln Grant From The Cancer Prevention & Research Institute Of Texas (Cprit)
17/12/2024 12:46
Dec 17 (Reuters) - Marker Therapeutics Inc MRKR.O :
* MARKER THERAPEUTICS AWARDED $9.5 MILLION GRANT FROM THE
CANCER
PREVENTION & RESEARCH INSTITUTE OF TEXAS (CPRIT) TO SUPPORT THE
INVESTIGATION OF MT-601 IN PATIENTS WITH PANCREATIC CANCER
* MARKER THERAPEUTICS: PLANS TO INVESTIGATE ITS POTENTIAL
APPLICATION BEYOND LYMPHOMA IN PATIENTS WITH SOLID TUMORS
* MARKER THERAPEUTICS INC: ANTICIPATES CLINICAL PROGRAM
INITIATION
IN 2025
Source text: ID:nGNX24rf9p
Further company coverage: MRKR.O
Recent news on Marker Therapeutics
See all newsBrief: Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant To Advance MT-601 In Pancreatic Cancer
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79